Compare OKUR & PLUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
Plutus Financial Group Ltd provides financial services. The company has two reportable segments: securities related services and asset management services. The securities related services segment generated commission by offering securities dealing and brokerage services, securities underwriting and placing services, and other financing services. The asset management services segment generated asset management fee by providing asset management services and investment advisory services.